Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Baxter International Inc.    BAX   US0718131099

Real-time Quote. Real-time BATS US - 06/18 04:59:58 pm
70.755 USD   +0.04%
5d agoDJLilly Ends Alzheimer's Drug Study On Safety Concern
06/05 BAXTER INTERNATIONAL INC.: ex-dividend day
05/30 BAXTER INTERNATIONAL INC.: StockCall Pre-Market Review on BAX, CFN, UNIS, ..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Baxter International Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales13 05613 89314 19015 55017 07017 782
Operating income (EBITDA)3 7283 9283 8674 1984 7315 003
Operating profit (EBIT)3 0433 2583 1553 4113 8444 134
Pre-Tax Profit (EBT)--2 889---
Net income1 4202 2242 3262 5182 8213 052
EPS ( $)2,393,884,184,575,205,70
Dividend per Share ( $)1,181,271,571,811,922,07
Yield1,69%1,82%2,25%2,60%2,75%2,96%
Announcement Date01/27/2011
12:00pm		01/26/2012
12:00pm		01/24/2013
12:05pm		---
Finances - Leverage
Baxter International Inc. : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt1 7022 2902 6606 0674 0322 969
Finance------
Operating income (EBITDA)3 7283 9283 8674 1984 7315 003
Leverage
(Debt/EBITDA)		0,46x0,58x0,69x1,45x0,85x0,59x
Capital Expenditure9639601 1611 6141 6261 451
Book Value Per Share (BVPS)11,3 $11,7 $12,7 $15,1 $18,2 $21,4 $
Cash Flow per Share5,06 $4,92 $5,59 $5,08 $6,27 $7,41 $
Announcement Date01/27/2011
12:00pm		01/26/2012
12:00pm		01/24/2013
12:05pm		---
Balance Sheet Analysis
Baxter International Inc. : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 37 801 M$ -
Company Value 43 868 M$ 41 833 M$
Valuation 2013e 2014e
PER (Price / EPS) 15,3x 13,4x
Capitalization / Revenue 2,43x 2,21x
EV / Revenue 2,82x 2,45x
EV / EBITDA 10,5x 8,84x
Yield (DPS / Price) 2,60% 2,75%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 21,9% 22,5%
operating laverage (Delta EBIT / Delta Sales) 0,85x 1,30x
Net Margin (Net Profit / Revenue) 16,2% 16,5%
ROA (Net Profit / Asset) 11,5% 11,5%
ROE (Net Profit / Equities) 32,8% 30,3%
Rate of Dividend 39,7% 37,0%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   10,4% 9,53%
Cash Flow / Sales (Taux d'autofinancement) 17,7% 19,9%
Capital Intensity (Assets / Sales) 1,41x 1,43x
Financial Leverage (Net Debt / EBITDA) 1,45x 0,85x
Price Earning Ratio
Baxter International Inc. : Price Earning Ratio
EPS & Dividend
Baxter International Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.